[Form 4] CME GROUP INC. Insider Trading Activity
Rhea-AI Filing Summary
Julie Winkler, Senior Managing Director and Chief Commercial Officer at CME Group (CME), reported insider transactions related to restricted stock vesting and tax-withholding on September 15-16, 2025. On 09/15/2025 she surrendered 1,081 shares at $258.83 to satisfy tax withholding upon vesting and received 3,044 shares at $258.83 from the vesting event, and on 09/16/2025 she surrendered 379 shares at $259.83 for tax withholding. After these transactions she beneficially owned 25,512 Class A shares. The Form 4 was signed on behalf of Ms. Winkler by Margaret Austin Wright on 09/17/2025. The filing shows routine equity vesting and share-withholding to cover taxes; no derivative transactions or additional compensatory arrangements are disclosed in this Form 4.
Positive
- Beneficial ownership increased to 25,512 Class A shares after the reported vesting and withholding transactions
Negative
- None.
Insights
TL;DR: Routine restricted-stock vesting and share surrender for tax withholding increased reported holdings to 25,512 Class A shares; not material to valuation.
This Form 4 documents an equity compensation vesting event and the statutory tax-withholding action that accompanied it. The reporting person received 3,044 Class A shares on 09/15/2025 and surrendered a total of 1,460 shares across 09/15-09/16/2025 to satisfy withholding, leaving 25,512 shares beneficially owned. These are standard insider compensation mechanics and do not indicate open-market purchases or sales for investment purposes. There are no derivative exercises or other transactions disclosed that would materially change outstanding insider exposure.
TL;DR: The filing reflects routine executive compensation administration; disclosures are clear and timely under Section 16 reporting rules.
The report names Ms. Julie Winkler and lists her role as Senior Managing Director Chief Commercial Officer. Transactions are identified with dates, quantities, and per-share amounts, and the explanatory remarks state that shares were surrendered to cover tax withholding upon vesting. The Form 4 appears properly completed and signed via authorized filer's signature dated 09/17/2025. No indications of unusual insider trading patterns or related-party transactions are present in this filing.